SKI Market

Indian Indices

Sensex

84,491.80 -188.06
( -0.22%)

Global Indices

Nasdaq

48,129.39 -308.18
(-0.64%)

Dow Jones

6,819.35 -18.16
(-0.27%)

Hang Seng

49,445.34 -722.77
(-1.44%)

Nikkei 225

9,668.67 -82.64
(-0.85%)

Forex

USD-INR

90.68 0.14
(0.16%)

EUR-INR

106.49 0.21
(0.20%)

GBP-INR

121.26 0.23
(0.19%)

JPY-INR

0.58 0.00
(0.55%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

330.3875196

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

34.16

32469.52

EPS(TTM)

Face Value()

Div & Yield %

76.07

1.08

Back

Mufin Green Finance board approves NCD issuance up to Rs 50 cr

Nov 20,2025

The board of Mufin Green Finance at its meeting held on 20 November 2025 has approved the issuance of listed, secured, non-convertible debentures on a private placement basis for an aggregate amount up to Rs 50 crore on a private placement.

84,491.80 -188.06 ( -0.22%)

48,129.39 -308.18 (-0.64%)

6,819.35 -18.16 (-0.27%)

49,445.34 -722.77 (-1.44%)

9,668.67 -82.64 (-0.85%)

90.68 0.14 (0.16%)

106.49 0.21 (0.20%)

121.26 0.23 (0.19%)

0.58 0.00 (0.55%)